125 related articles for article (PubMed ID: 10378671)
1. Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma.
Gravis G; Pech-Gourgh F; Viens P; Alzieu C; Camerlo J; Oziel-Taieb S; Jausseran M; Maraninchi D
Anticancer Drugs; 1999 Apr; 10(4):369-74. PubMed ID: 10378671
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
Hussain M; Benedetti J; Smith RE; Rodriguez GI; Schuller D; Ensley J
Cancer; 1995 Oct; 76(7):1233-7. PubMed ID: 8630903
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics.
Goncalves A; Camerlo J; Bun H; Gravis G; Genre D; Bertucci F; Resbeut M; Pech-Gourg F; Durand A; Maraninchi D; Viens P
Anticancer Res; 2001; 21(2B):1431-7. PubMed ID: 11396227
[TBL] [Abstract][Full Text] [Related]
5. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
Recchia F; Lalli A; Lombardo M; De Filippis S; Saggio G; Fabbri F; Rosselli M; Capomolla E; Rea S
Cancer; 2001 Aug; 92(4):814-21. PubMed ID: 11550152
[TBL] [Abstract][Full Text] [Related]
8. Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma.
Enzinger PC; Ilson DH; Saltz LB; Martin LK; Kelsen DP
Cancer; 1999 Mar; 85(6):1213-7. PubMed ID: 10189124
[TBL] [Abstract][Full Text] [Related]
9. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.
Lippman SM; Parkinson DR; Itri LM; Weber RS; Schantz SP; Ota DM; Schusterman MA; Krakoff IH; Gutterman JU; Hong WK
J Natl Cancer Inst; 1992 Feb; 84(4):235-41. PubMed ID: 1734084
[TBL] [Abstract][Full Text] [Related]
10. Concomitant alpha-interferon and chemotherapy in advanced squamous cell carcinoma of the head and neck.
Benasso M; Merlano M; Blengio F; Cavallari M; Rosso R; Toma S
Am J Clin Oncol; 1993 Dec; 16(6):465-8. PubMed ID: 8256758
[TBL] [Abstract][Full Text] [Related]
11. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
[TBL] [Abstract][Full Text] [Related]
12. Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study.
Nikolaou AC; Fountzilas G; Daniilidis I
J Laryngol Otol; 1996 Sep; 110(9):857-61. PubMed ID: 8949297
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer.
Voravud N; Lippman SM; Weber RS; Rodriquez GI; Yee D; Dimery IW; Earley CL; Von Hoff DD; Hong WK
Invest New Drugs; 1993 Feb; 11(1):57-60. PubMed ID: 8349437
[TBL] [Abstract][Full Text] [Related]
14. Phase I-II trial of recombinant interferon alpha-2b with cisplatin and 5-fluorouracil in recurrent and/or metastatic carcinoma of head and neck.
Bensmaine ME; Azli N; Domenge C; Armand JP; Cvitkovic E
Am J Clin Oncol; 1996 Jun; 19(3):249-54. PubMed ID: 8638535
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of treatment with oral 13-cis-retinoic acid, subcutaneous interferon alfa-2a, cisplatin, and 24-hour infusion 5-fluorouracil/leucovorin.
Fleming GF; O'Brien SM; Hoffman PC; Vokes EE; Vogelzang NJ; Schilsky RL; Waggoner SE; Ratain MJ
Cancer Chemother Pharmacol; 1997; 39(3):227-32. PubMed ID: 8996525
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).
Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ
Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008
[TBL] [Abstract][Full Text] [Related]
17. Combination of alpha-interferon 2a (alpha-IFN 2a) and 13-cis-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN).
Toma S; Airoldi M; Palumbo R; Raffo P; Bumma C
Int J Cancer; 1997 Feb; 70(4):491-3. PubMed ID: 9033664
[No Abstract] [Full Text] [Related]
18. Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus.
Damle S; Beitler JJ; Haynes H; Camacho M; Wolf E; Wadler S
Am J Clin Oncol; 1999 Aug; 22(4):391-5. PubMed ID: 10440197
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix.
Hallum AV; Alberts DS; Lippman SM; Inclan L; Shamdas GJ; Childers JM; Surwit EA; Modiano M; Hatch KD
Gynecol Oncol; 1995 Mar; 56(3):382-6. PubMed ID: 7705672
[TBL] [Abstract][Full Text] [Related]
20. Combination of cisplatin and interferon-alpha 2a (Roferon-A) in patients with non-small cell lung cancer (NSCLC). An open phase II multicentre study.
Kataja V; Yap A
Eur J Cancer; 1995; 31A(1):35-40. PubMed ID: 7695976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]